Market News

Croda International PLC (LON:CRDA) “Neutral” Rating Has Just Been Reiterated by Goldman Sachs

Croda International PLC (LON:CRDA) “Neutral” Rating Has Just Been Reiterated by Goldman Sachs

Investors sentiment increased to 1.63 in Q3 2018. Its up 0.49, from 1.14 in 2018Q2. It increased, as 3 investors sold Croda International Plc shares while 16 reduced holdings. 9 funds opened positions while 22 raised stakes. 8.43 million shares or 6.76% more from 7.90 million shares in 2018Q2 were […]

Investor Outlook: Future PLC (LON:FUTR) “Buy” Rating Maintained at Peel Hunt Today

Investor Outlook: Future PLC (LON:FUTR) “Buy” Rating Maintained at Peel Hunt Today

Future PLC (LON:FUTR) Rating Reaffirmed Peel Hunt reaffirmed their “Buy” rating on Future PLC (LON:FUTR) shards via a note sent to clients and investors on Monday, 18 February. Future plc (LON:FUTR) Ratings Coverage Among 2 analysts covering Future PLC (LON:FUTR), 2 have Buy rating, 0 Sell and 0 Hold. Therefore […]

EPS for AAR Corp. (AIR) Expected At $0.69

EPS for AAR Corp. (AIR) Expected At $0.69

Investors sentiment increased to 1.58 in Q3 2018. Its up 0.12, from 1.46 in 2018Q2. It improved, as 16 investors sold AAR Corp. shares while 46 reduced holdings. 42 funds opened positions while 56 raised stakes. 30.33 million shares or 6.37% less from 32.39 million shares in 2018Q2 were reported. […]

AC Immune SA (ACIU) EPS Estimated At $0.12

AC Immune SA (ACIU) EPS Estimated At $0.12

Analysts expect AC Immune SA (NASDAQ:ACIU) to report $0.12 EPS on March, 19.They anticipate $0.06 EPS change or 100.00 % from last quarter’s $0.06 EPS. ACIU’s profit would be $8.08 million giving it 8.27 P/E if the $0.12 EPS is correct. After having $-0.19 EPS previously, AC Immune SA’s analysts […]

Luxfer Holdings PLC (LXFR) Analysts See $0.31 EPS

Analysts expect Luxfer Holdings PLC (NYSE:LXFR) to report $0.31 EPS on March, 18.They anticipate $0.12 EPS change or 63.16 % from last quarter’s $0.19 EPS. LXFR’s profit would be $8.22M giving it 16.05 P/E if the $0.31 EPS is correct. After having $0.50 EPS previously, Luxfer Holdings PLC’s analysts see […]

EPS for Canadian Solar Inc. (CSIQ) Expected At $0.59

EPS for Canadian Solar Inc. (CSIQ) Expected At $0.59

Analysts expect Canadian Solar Inc. (NASDAQ:CSIQ) to report $0.59 EPS on March, 18.They anticipate $0.42 EPS change or 41.58 % from last quarter’s $1.01 EPS. CSIQ’s profit would be $34.56M giving it 8.70 P/E if the $0.59 EPS is correct. After having $0.96 EPS previously, Canadian Solar Inc.’s analysts see […]

Apellis Pharmaceuticals, Inc. (APLS) EPS Estimated At $-0.65

Apellis Pharmaceuticals, Inc. (APLS) EPS Estimated At $-0.65

Analysts expect Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) to report $-0.65 EPS on March, 18.They anticipate $0.05 EPS change or 8.33 % from last quarter’s $-0.6 EPS. After having $-0.64 EPS previously, Apellis Pharmaceuticals, Inc.’s analysts see 1.56 % EPS growth. The stock decreased 2.60% or $0.37 during the last trading session, […]

Sorrento Therapeutics, Inc. (SRNE) Analysts See $-0.27 EPS

Sorrento Therapeutics, Inc. (SRNE) Analysts See $-0.27 EPS

Investors sentiment decreased to 1.15 in Q3 2018. Its down 1.27, from 2.42 in 2018Q2. It worsened, as 12 investors sold Sorrento Therapeutics, Inc. shares while 21 reduced holdings. 15 funds opened positions while 23 raised stakes. 31.19 million shares or 10.80% more from 28.15 million shares in 2018Q2 were […]

EPS for Nabriva Therapeutics plc (NBRV) Expected At $-0.34

EPS for Nabriva Therapeutics plc (NBRV) Expected At $-0.34

Analysts expect Nabriva Therapeutics plc (NASDAQ:NBRV) to report $-0.34 EPS on March, 15.They anticipate $0.26 EPS change or 43.33 % from last quarter’s $-0.6 EPS. After having $-0.35 EPS previously, Nabriva Therapeutics plc’s analysts see -2.86 % EPS growth. The stock increased 1.48% or $0.03 during the last trading session, […]

$-0.01 EPS Expected for MoneyGram International, Inc. (MGI)

$-0.01 EPS Expected for MoneyGram International, Inc. (MGI)

Investors sentiment increased to 1.71 in 2018 Q3. Its up 0.79, from 0.92 in 2018Q2. It improved, as 11 investors sold MoneyGram International, Inc. shares while 23 reduced holdings. 21 funds opened positions while 37 raised stakes. 44.72 million shares or 0.57% less from 44.98 million shares in 2018Q2 were […]